These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32364521)

  • 1. Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer.
    Lepara Z; Lepara O; Fajkić A; Rebić D; Alić J; Spahović H
    Rom J Intern Med; 2020 Sep; 58(3):146-152. PubMed ID: 32364521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant status in patients with bladder cancer regarding cancer stage and grade.
    Lepara Z; Alić J; Lepara O; Spahović H; Fajkić A
    Asian J Urol; 2023 Apr; 10(2):182-188. PubMed ID: 36942120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.
    Gecit I; Aslan M; Gunes M; Pirincci N; Esen R; Demir H; Ceylan K
    J Cancer Res Clin Oncol; 2012 May; 138(5):739-43. PubMed ID: 22258852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE RELATIONSHIP BETWEEN SERUM LEVEL OF MALONDIALDEHYDE AND PROGRESSION OF COLORECTAL CANCER.
    Rašić I; Rašić A; Akšamija G; Radović S
    Acta Clin Croat; 2018 Sep; 57(3):411-416. PubMed ID: 31168172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
    Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
    Cimen HI; Halis F; Saglam HS; Gokce A
    Int Braz J Urol; 2017; 43(1):67-72. PubMed ID: 28124528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
    Wang Z; Li H; Chi Q; Qiu Y; Li X; Xin L
    Med Sci Monit; 2018 Jun; 24():3882-3887. PubMed ID: 29883442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced oxidation protein products and malondialdehyde - the new biological markers of oxidative stress - are elevated in postmenopausal women.
    Cakir T; Goktas B; Mutlu MF; Mutlu I; Bilgihan A; Erdem M; Erdem A
    Ginekol Pol; 2016; 87(5):321-5. PubMed ID: 27304645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
    Kimura S; Soria F; D'Andrea D; Foerster B; Abufaraj M; Vartolomei MD; Karakiewicz PI; Mathieu R; Moschini M; Rink M; Egawa S; Shariat SF; Gust KM
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1123-e1132. PubMed ID: 30061034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic potential of YKL-40 in bladder cancer.
    Yasar O; Akcay T; Obek C; Turegun FA
    Urol Oncol; 2016 Jun; 34(6):257.e19-24. PubMed ID: 26961673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-18 and nitric oxide activity in bladder carcinoma.
    Bukan N; Sözen S; Coskun U; Sancak B; Günel N; Bozkirli I; Senocak C
    Eur Cytokine Netw; 2003; 14(3):163-7. PubMed ID: 14656691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Biological Effective Monitoring of Chrome Electroplaters to Chromium through Analysis of Serum Malondialdehyde.
    Mozafari P; Rezazadeh Azari M; Shokoohi Y; Sayadi M
    Int J Occup Environ Med; 2016 Oct; 7(4):199-206. PubMed ID: 27651080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
    Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
    J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Utility of Serum Golgi Phosphoprotein 3 in Bladder Cancer Patients.
    Lu J; Zhong F; Sun B; Wang C
    Med Sci Monit; 2019 Sep; 25():6736-6741. PubMed ID: 31494662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
    Yasar O; Akcay T; Obek C; Turegun FA
    Scand J Clin Lab Invest; 2017 Oct; 77(6):437-441. PubMed ID: 28609200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.
    Sawicka E; Kratz EM; Szymańska B; Guzik A; Wesołowski A; Kowal P; Pawlik-Sobecka L; Piwowar A
    Pathol Oncol Res; 2020 Apr; 26(2):821-831. PubMed ID: 30828780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.